Please Wait.....
Report
Europe Uro-Gynecology Market
Market Report I 2025-08-01 I 350 Pages I Data Bridge Market Research
Europe Uro-Gynecology Market is expected to reach USD 13,773,293.50 thousand by 2032 from USD 7,766,725.15 thousand in 2024, growing at the CAGR of 7.5% in the forecast period of 2025 to 2032.
Market Segmentation:
Europe Uro-Gynecology Market, By Product (Urinary Incontinence Devices, Pelvic Organ Prolapse Devices and Others), By Biomaterial Type (Synthetic Biomaterials, Natural Biomaterials and Others), By Material Form (Knitted Meshes, Scaffolds, Injectable Gels and Others), By Indication (Urinary Incontinence and Pelvic Organ Prolapse), By End User (Hospitals, Ambulatory Surgical Centers (Ascs), Specialty Clinics, Academic & Research Institutes, Home Care Settings and Others), By Distribution Channel (Direct Tenders, Online, Retail Stores and Others), By Country (Germany, U.K., France, Italy, Spain, Switzerland, Russia, Turkey, Belgium, Netherlands, Denmark, Poland, Sweden, Norway, Finland and Rest of Europe) - Industry Trends and Forecast To 2032.
Overview of Europe uro-gynecology Market Dynamics:
Driver
- Rising prevalence of pelvic floor disorders
Restraints
- Rising prevalence of pelvic floor disorders
Opportunities
- Rising prevalence of pelvic floor disorders
Market Players:
The key players operating in the Europe uro-gynecology market are:
- Johnson & Johnson Services, Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- Coloplast Corp (Denmark)
- Medtronic (Ireland)
- Cook (U.S.)
- Teleflex Incorporated (U.S.)
- Convatec Group PLC (U.K.)
- Hollister Incorporated (U.S.)
- Integer Holdings Corporation (U.S.)
- Laborie (U.S.)
- B. Braun SE (Germany)
- Synkotech Biocompatible Materials SI (Spain)
- NEOMEDIC (Spain)
- Betatech Medical (Turkey)
- W. L. Gore & Associates, Inc. (U.S.)
- pfm medical gmbh (Germany)
- high standArt networks, Osnabruck (U.S.)
- Promedon Group (Bolivia)
TABLE OF CONTENTS
1 INTRODUCTION 38
1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
1.3 OVERVIEW OF EUROPE URO-GYNECOLOGY MARKET 38
1.4 MARKETS COVERED 40
2 MARKET SEGMENTATION 44
2.1 MARKETS COVERED 44
2.2 GEOGRAPHICAL SCOPE 45
2.3 YEARS CONSIDERED FOR THE STUDY 46
2.4 CURRENCY AND PRICING 46
2.5 DBMR TRIPOD DATA VALIDATION MODEL 47
2.6 MULTIVARIATE MODELLING 50
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.8 DBMR MARKET POSITION GRID 52
2.9 VENDOR SHARE ANALYSIS 53
2.10 MARKET END USER COVERAGE GRID 54
2.11 SECONDARY SOURCES 55
2.12 ASSUMPTIONS 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHT 61
4.1 PORTER'S FIVE FORCES 62
4.2 INNOVATION TRACKER AND STRATEGIC ANALYSIS. 63
4.2.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS 63
4.2.1.1 Joint Ventures 63
4.2.1.2 Mergers and Acquisitions 63
4.2.1.3 Licensing and Partnership 63
4.2.1.4 Technology Collaborations 63
4.2.1.5 Strategic Divestments 63
4.2.2 NUMBER OF PRODUCTS IN DEVELOPMENT 63
4.2.3 STAGE OF DEVELOPMENT 63
4.2.4 TIMELINES AND MILESTONES 63
4.2.5 INNOVATION STRATEGIES AND METHODOLOGIES 64
4.2.6 RISK ASSESSMENT AND MITIGATION 64
4.2.7 FUTURE OUTLOOK 64
4.3 TECHNOLOGICAL ADVANCEMENTS. 65
4.3.1 ADVANCED BIOMATERIALS FOR IMPLANTS AND MESHES 65
4.3.2 INJECTABLE THERAPIES WITH ENHANCED BIOMATERIALS 65
4.3.3 SMART ARTIFICIAL URINARY SPHINCTERS (AUS) 65
4.3.4 TISSUE ENGINEERING & 3D BIOPRINTING 65
4.3.5 INTEGRATION OF AI AND DIGITAL HEALTH PLATFORMS 66
4.3.6 ROBOTIC-ASSISTED AND MINIMALLY INVASIVE SURGERY 66
4.3.7 REGENERATIVE MEDICINE & STEM CELL THERAPY 66
4.3.8 NOVEL DRUG-DELIVERY DEVICES 66
4.4 VALUE CHAIN ANALYSIS 67
4.4.1 RAW MATERIAL SUPPLY 67
4.4.2 COMPONENT MANUFACTURING AND PROCESSING 67
4.4.3 MEDICAL DEVICE ASSEMBLY AND OEM DEVELOPMENT 67
4.4.4 DISTRIBUTION AND LOGISTICS 67
4.4.5 HOSPITALS, CLINICS, AND SURGICAL CENTERS (END USERS) 67
4.4.6 PATIENTS AND CONSUMERS 68
4.4.7 SUPPORT SERVICES (CROSS-CUTTING LAYER) 68
4.5 BRAND OUTLOOK 69
4.5.1 BRAND COMPARATIVE ANALYSIS OF EUROPE URO-GYNECOLOGY MARKET 69
4.5.2 PRODUCT VS BRAND OVERVIEW 70
4.5.3 PRODUCT OVERVIEW 71
4.5.4 BRAND OVERVIEW 71
4.6 PRICING ANALYSIS 72
4.6.1 PREMIUM PRICING FOR ADVANCED DEVICES 72
4.6.2 COMPETITIVE PRICING FOR CONSUMABLES 72
4.6.3 IMPACT OF BRAND AND REGION 72
4.6.4 TRENDS IN PRICING STRATEGIES 72
4.7 RAW MATERIAL COVERAGE 73
4.7.1 POLYPROPYLENE (PP) 73
4.7.2 OTHER SYNTHETIC POLYMERS 73
4.7.3 BIOLOGIC MESH MATERIALS 73
4.7.4 MEDICAL-GRADE SILICONE 73
4.7.5 CERAMIC OR BIOCERAMIC MATERIALS 74
4.8 SURGICAL PROCEDURE NUMBERS 75
4.8.1 OVERVIEW 75
4.8.2 TISSUE ENGINEERED MATERIALS & SCAFFOLDS 75
4.8.3 BIODEGRADABLE COMPOSITE MESH 75
4.8.4 TISSUE INTEGRATION & INFLAMMATION CONTROL 75
4.8.5 REGULATORY LANDSCAPE & SAFETY REASSESSMENT 75
4.8.6 SURGICAL PROCEDURE VOLUMES: EUROPE ESTIMATES & TRENDS 75
4.8.7 TRENDS 75
4.8.8 CONCLUSION 76
4.9 COMPANY EVALUATION QUADRANT 77
4.10 PRODUCTION CONSUMPTION ANALYSIS 78
4.11 COST ANALYSIS BREAKDOWN 79
4.11.1 RESEARCH & DEVELOPMENT (R&D) COSTS (15-25%) 79
4.11.2 RAW MATERIAL AND COMPONENT COSTS (20-30%) 79
4.11.3 MANUFACTURING COSTS (15-20%) 79
4.11.4 REGULATORY & QUALITY COMPLIANCE (5-10%) 79
4.11.5 MARKETING & PROMOTION (10-15%) 79
4.11.6 DISTRIBUTION & LOGISTICS (5-10%) 80
4.11.7 LICENSING, ROYALTIES & IP MANAGEMENT (1-3%) 80
4.11.8 TRAINING, CLINICAL SUPPORT & AFTER-SALES (2-5%) 80
4.12 TARIFFS & IMPACT ON THE MARKET 81
4.12.1 CURRENT TARIFF RATE(S) IN TOP 5 COUNTRY MARKETS 81
4.12.2 OUTLOOK: LOCAL PRODUCTION VS IMPORT RELIANCE 81
4.12.3 VENDOR SELECTION CRITERIA DYNAMICS 81
4.12.4 IMPACT ON SUPPLY CHAIN 81
4.12.4.1 Raw Material Procurement 81
4.12.4.2 Manufacturing and Production 81
4.12.4.3 Logistics and Distribution 81
4.12.4.4 Price Pitching and Market Position 82
4.12.5 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 82
4.12.5.1 Supply Chain Optimization 82
4.12.5.2 Joint Venture Establishments 82
4.12.6 IMPACT ON PRICES 82
4.12.7 REGULATORY INCLINATION 82
4.12.7.1 Geopolitical Situation 82
4.12.7.2 Trade Partnerships Between the Countries 82
4.12.7.2.1 Free Trade Agreements 82
4.12.7.2.2 Alliances Establishments 82
4.12.7.3 Status Accreditation (Including MFTN) 83
4.12.7.4 Domestic Course of Correction 83
4.12.7.4.1 Establishment of Special Economic Zones / Industrial Parks 83
5 REGULATION COVERAGE. 84
5.1 NORTH AMERICA 84
5.1.1 PRODUCT CODES 84
5.1.2 CERTIFIED STANDARDS 84
5.1.3 SAFETY STANDARDS 84
5.1.4 MATERIAL HANDLING & STORAGE 85
5.1.5 TRANSPORT & PRECAUTIONS 85
5.1.6 HAZARD IDENTIFICATION 85
5.2 SOUTH AMERICA 86
5.2.1 PRODUCT CODES 86
5.2.2 CERTIFIED STANDARDS 86
5.2.3 SAFETY STANDARDS 86
5.2.3.1 MATERIAL HANDLING & STORAGE 86
5.2.3.2 TRANSPORT & PRECAUTIONS 86
5.2.3.3 HAZARD IDENTIFICATION 86
5.3 EUROPE 87
5.3.1 PRODUCT CODES 87
5.4 CERTIFIED STANDARDS 87
5.4.1 SAFETY STANDARDS 87
5.4.1.1 MATERIAL HANDLING & STORAGE 87
5.4.1.2 TRANSPORT & PRECAUTIONS 87
5.4.1.3 HAZARD IDENTIFICATION 87
5.5 ASIA-PACIFIC 88
5.5.1 PRODUCT CODES 88
5.5.2 CERTIFIED STANDARDS 88
5.5.3 SAFETY STANDARDS 88
5.5.3.1 MATERIAL HANDLING & STORAGE 88
5.5.3.2 TRANSPORT & PRECAUTIONS 89
5.5.3.3 HAZARD IDENTIFICATION 89
5.6 MIDDLE EAST AND AFRICA 89
5.6.1 PRODUCT CODES 89
5.6.2 CERTIFIED STANDARDS 89
5.6.3 SAFETY STANDARDS 90
5.6.3.1 MATERIAL HANDLING & STORAGE 90
5.6.3.2 TRANSPORT & PRECAUTIONS 90
5.6.3.3 HAZARD IDENTIFICATION 90
6 MARKET OVERVIEW 91
6.1 DRIVERS 93
6.1.1 RISING PREVALENCE OF PELVIC FLOOR DISORDERS 93
6.1.2 GROWING AWARENESS ABOUT FEMALE REPRODUCTIVE HEALTH ISSUES 93
6.1.3 ADVANCEMENTS IN UROGYNECOLOGICAL SURGICAL DEVICE TECHNOLOGY 95
6.1.4 INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES 96
6.2 RESTRAINTS 97
6.2.1 STRINGENT REGULATORY FRAMEWORK 97
6.2.2 HIGH COST OF TREATMENT AND EQUIPMENT 97
6.3 OPPORTUNITIES 99
6.3.1 UNTAPPED EMERGING MARKETS 99
6.3.2 INNOVATION IN NON-SURGICAL TREATMENTS 99
6.3.3 PUBLIC-PRIVATE PARTNERSHIPS TO EXPAND AWARENESS AND ACCESS 101
6.4 CHALLENGES 102
6.4.1 INADEQUATE REIMBURSEMENT RATE 102
6.4.2 REPUTATION DAMAGE FROM PAST PRODUCT FAILURES 102
7 EUROPE URO-GYNECOLOGY MARKET, BY PRODUCT 104
7.1 OVERVIEW 105
7.2 URINARY INCONTINENCE DEVICES 108
7.3 PELVIC ORGAN PROLAPSE DEVICES 111
7.4 OTHERS 113
8 EUROPE URO-GYNECOLOGY MARKET, BY BIOMATERIAL TYPE 114
8.1 OVERVIEW 115
8.2 SYNTHETIC BIOMATERIALS 118
8.3 NATURAL BIOMATERIALS 119
8.4 OTHERS 120
9 EUROPE URO-GYNECOLOGY MARKET, BY MATERIAL FORM 121
9.1 OVERVIEW 122
9.2 KNITTED MESHES 125
9.3 SCAFFOLDS 125
9.4 INJECTABLE GELS 126
9.5 OTHERS 126
10 EUROPE URO-GYNECOLOGY MARKET, BY INDICATION 127
10.1 OVERVIEW 128
10.2 URINARY INCONTINENCE 131
10.3 PELVIC ORGAN PROLAPSE 132
11 EUROPE URO-GYNECOLOGY MARKET, BY END-USER 133
11.1 OVERVIEW 134
11.2 HOSPITALS 137
11.3 AMBULATORY SURGICAL CENTERS (ASCS) 138
11.4 SPECIALTY CLINICS 139
11.5 ACADEMIC & RESEARCH INSTITUTES 139
11.6 HOME CARE SETTINGS 140
11.7 OTHERS 140
12 EUROPE URO-GYNECOLOGY MARKET, BY DISTRIBUTION CHANNEL 141
12.1 OVERVIEW 142
12.2 DIRECT TENDERS 145
12.3 ONLINE 145
12.4 RETAIL STORES 146
12.5 OTHERS 146
13 EUROPE URO-GYNECOLOGY MARKET, BY REGION 147
13.1 EUROPE 149
13.1.1 GERMANY 160
13.1.2 U.K. 169
13.1.3 ITALY 178
13.1.4 FRANCE 187
13.1.5 SPAIN 196
13.1.6 SWITZERLAND 205
13.1.7 RUSSIA 214
13.1.8 TURKEY 223
13.1.9 BELGIUM 232
13.1.10 NETHERLANDS 241
13.1.11 DENMARK 250
13.1.12 NORWAY 259
13.1.13 FINLAND 268
13.1.14 SWEDEN 277
13.1.15 REST OF EUROPE 286
14 EUROPE URO-GYNECOLOGY MARKET, COMPANY LANDSCAPE 287
14.1 COMPANY SHARE ANALYSIS: GLOBAL 287
15 SWOT ANALYSIS 288
16 COMPANY PROFILE 289
16.1 BOSTON SCIENTIFIC CORPORATION 289
16.1.1 COMPANY SNAPSHOT 289
16.1.2 REVENUE ANALYSIS 290
16.1.3 COMPANY SHARE ANALYSIS 290
16.1.4 PRODUCT PORTFOLIO 291
16.1.5 RECENT DEVELOPMENTS/NEWS 292
16.2 JOHNSON & JOHNSON SERVICES, INC. 293
16.2.1 COMPANY SNAPSHOT 293
16.2.2 REVENUE ANALYSIS 293
16.2.3 COMPANY SHARE ANALYSIS 294
16.2.4 PRODUCT PORTFOLIO 294
16.2.5 RECENT DEVELOPMENT 296
16.3 MEDTRONIC 297
16.3.1 COMPANY SNAPSHOT 297
16.3.2 REVENUE ANALYSIS 297
16.3.3 COMPANY SHARE ANALYSIS 298
16.3.4 PRODUCT PORTFOLIO 298
16.3.5 RECENT DEVELOPMENT 299
16.4 COOK 300
16.4.1 COMPANY SNAPSHOT 300
16.4.2 COMPANY SHARE ANALYSIS 300
16.4.3 PRODUCT PORTFOLIO 301
16.4.4 RECENT DEVELOPMENT 301
16.5 TELEFLEX INCORPORATED 302
16.5.1 COMPANY SNAPSHOT 302
16.5.2 REVENUE ANALYSIS 302
16.5.3 COMPANY SHARE ANALYSIS 303
16.5.4 PRODUCT PORTFOLIO 303
16.5.5 RECENT DEVELOPMENT 303
16.6 AMERICAN MEDICAL SYSTEMS 304
16.6.1 COMPANY SNAPSHOT 304
16.6.2 PRODUCT PORTFOLIO 304
16.6.3 RECENT DEVELOPMENT 304
16.7 B. BRAUN SE 305
16.7.1 COMPANY SNAPSHOT 305
16.7.2 REVENUE ANALYSIS 305
16.7.3 PRODUCT PORTFOLIO 306
16.7.4 RECENT DEVELOPMENT 307
16.8 BETATECH MEDICAL 308
16.8.1 COMPANY SNAPSHOT 308
16.8.2 PRODUCT PORTFOLIO 308
16.8.3 RECENT DEVELOPMENT 309
16.9 BEZWADA BIOMEDICAL, LLC 310
16.9.1 COMPANY SNAPSHOT 310
16.9.2 PRODUCT PORTFOLIO 310
16.9.3 RECENT DEVELOPMENT 312
16.10 BIOSEAL INC 313
16.10.1 COMPANY SNAPSHOT 313
16.10.2 PRODUCT PORTFOLIO 313
16.10.3 RECENT DEVELOPMENT 318
16.11 CALDERA MEDICAL 319
16.11.1 COMPANY SNAPSHOT 319
16.11.2 PRODUCT PORTFOLIO 319
16.11.3 RECENT DEVELOPMENT 319
16.12 COLOPLAST 320
16.12.1 COMPANY SNAPSHOT 320
16.12.2 REVENUE ANALYSIS 320
16.12.3 RODUCT PORTFOLIO 321
16.12.4 RECENT DEVELOPMENT/NEWS 322
16.13 CONVATEC GROUP PLC 323
16.13.1 COMPANY SNAPSHOT 323
16.13.2 REVENUE ANALYSIS 323
16.13.3 PRODUCT PORTFOLIO 324
16.13.4 RECENT DEVELOPMENT 324
16.14 COOPER SURGICAL, INC. 325
16.14.1 COMPANY SNAPSHOT 325
16.14.2 PRODUCT PORTFOLIO 325
16.14.3 RECENT DEVELOPMENT 325
16.15 DYNAMESH 326
16.15.1 COMPANY SNAPSHOT 326
16.15.2 PRODUCT PORTFOLIO 326
16.15.3 RECENT DEVELOPMENT 327
16.16 HOLLISTER INCORPORATED 328
16.16.1 COMPANY SNAPSHOT 328
16.16.2 PRODUCT PORTFOLIO 328
16.16.3 RECENT DEVELOPMENT 329
16.17 INTEGER HOLDINGS CORPORATION 330
16.17.1 COMPANY SNAPSHOT 330
16.17.2 REVENUE ANALYSIS 331
16.17.3 PRODUCT PORTFOLIO 331
16.17.4 RECENT DEVELOPMENTS 335
16.18 LABORIE 336
16.18.1 COMPANY SNAPSHOT 336
16.18.2 PRODUCT PORTFOLIO 336
16.18.3 RECENT DEVELOPMENT 337
16.19 NEOMEDIC INTERNATIONAL 338
16.19.1 COMPANY SNAPSHOT 338
16.19.2 PRODUCT PORTFOLIO 338
16.19.3 RECENT DEVELOPMENT 339
16.20 PFM MEDICAL GMBH 340
16.20.1 COMPANY SNAPSHOT 340
16.20.2 PRODUCT PORTFOLIO 340
16.20.3 RECENT DEVELOPMENT 341
16.21 POLY-MED INCORPORATED 342
16.21.1 COMPANY SNAPSHOT 342
16.21.2 PRODUCT PORTFOLIO 342
16.21.3 RECENT DEVELOPMENTS/NEWS 345
16.22 PROMEDON 346
16.22.1 COMPANY SNAPSHOT 346
16.22.2 SOLUTION PORTFOLIO 346
16.22.3 RECENT DEVELOPMENT 347
16.23 SYNKOTECH BIOCOMPATIBLE MATERIALS SL 348
16.23.1 COMPANY SNAPSHOT 348
16.23.2 PRODUCT PORTFOLIO 348
16.23.3 RECENT DEVELOPMENTS/NEWS 349
16.24 W. L. GORE & ASSOCIATES, INC. 350
16.24.1 COMPANY SNAPSHOT 350
16.24.2 PRODUCT PORTFOLIO 350
16.24.3 RECENT DEVELOPMENT 351
17 QUESTIONNAIRE 352
18 RELATED REPORTS 355
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security